Results 121 to 130 of about 48,929 (237)
Current Management of In-Stent Restenosis
In-stent restenosis (ISR) remains the primary cause of target lesion failure following percutaneous coronary intervention (PCI), resulting in 10-year incidences of target lesion revascularization at a rate of approximately 20%. The treatment of ISR is challenging due to its inherent propensity for recurrence and varying susceptibility to available ...
Giacoppo, Daniele +2 more
openaire +2 more sources
The Role Of Inflammation In Stent Restenosis More Than 1 Year Afetr Drug Eluting Stent Implantation
Background: In stent restenosis (ISR) following endovascular interventions is the main limitation of their long-term success. Despite advances have been made during recent years to decrease restenosis, it remains a challenging clinical problem.The aim of
Hasan Shemirani +2 more
doaj
BACKGROUND: The association between epicardial fat and coronary in-stent restenosis hasnot been evaluated. The objective of the present study was to evaluate the relationship ofechocardiographic epicardial fat thickness (EFT) with restenosis in drug ...
Fariborz Nikaeen +4 more
doaj
Small coronary vessel angioplasty: outcomes and technical considerations
Sudhir RathoreDepartment of Cardiology, Atkinson Morley wing, St George’s Healthcare NHS Trust, London, UKAbstract: Small vessel (<3 mm) coronary artery disease is common and has been identified as independent predictor of restenosis ...
Sudhir Rathore
doaj
Recurrent In-Stent Restenosis Treated With a Novel Technique: The Double-DCB Technique. [PDF]
Ang AS +4 more
europepmc +1 more source
CTRP12: A Novel Biomarker in Predicting In-Stent Restenosis Occurrence. [PDF]
Nie Y, Song W.
europepmc +1 more source
Lyudmila Pivina,1 Gulnara Batenova,1 Nazarbek Omarov,1 Diana Ygiyeva,1 Assylzhan Messova,1 Galiya Alibayeva,2 Ulzhan Jamedinova,1 Ruslan Kurumbayev,1 Maksim Pivin3 1Department of Emergency Medicine, Semey Medical University, Semey, Abay Region ...
Pivina L +8 more
doaj

